Interesting, where did you get such information from - the Company or is it some document somewhere?
I am new to GTG and have been doing some reading and couldnt find anything re patent expiry. Also should we be worried re the ASIC issue given it involves someone who you say is responsible for all the licensing revenues? I am not yet sure about Brevagen as here in the US these things take time, always more than you think, and the economy is in a hell of a mess.
Finally where did you get the figure of $50m, is that on the public record?
Many thanks
- Forums
- ASX - By Stock
- GTG
- patently clear facts re gtg !!!
GTG
genetic technologies limited
Add to My Watchlist
0.00%
!
3.9¢

patently clear facts re gtg !!!, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
3.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $52.08M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
GTG (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online